Additionally, plasma hyaluronidase activity was higher in the ICU COVID-19 patients vs. the non-ICU patients, and plasma MMP2, MMP9 and cathepsin D activities (enzymes which may cleave GAG-anchoring proteins) were significantly increased in COVID-19 patients vs. healthy controls (60). This evidence concerns the gene MMP2 and COVID-19.